China Shows Sharp Decline In Registration Approval Of Generic Drugs Last Year
This article was originally published in PharmAsia News
Last year, China's State FDA approved the registration applications of 651 generic drugs, constituting 73 percent of the year's approved 1,000 applications and dropping by 11 times from 2005, according to a recent SFDA conference on drug registration
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.